Biotinylation: a simple method for labelling complement component C8 with preservation of functional activity.

S Bhakdi; M Roth; F Hugo

doi:10.1016/0022-1759(89)90420-1

Home/Archive/PubMed

PubMed · 2754261

Biotinylation: a simple method for labelling complement component C8 with preservation of functional activity.

S Bhakdi·M Roth·F Hugo

View original source ↗Export metadata ↓

Abstract

Biotinylation of human C8 with the water-soluble biotin derivative biotinylamidohexanoic acid, N-hydroxysulfosuccinimide ester is an excellent method for labelling this terminal complement component with preservation of its functional activity. The biotinylated product can be detected both in native form and also following its incorporation into the terminal complement complexes. Detection assays include Western blotting, crossed immunoblotting, ELISA, and immunocytochemistry. Biotinylation is an attractive alternative method for labelling C8 and may be used for detecting and quantifying C8 and C5b-9 complexes in their soluble and membrane-bound forms.

Explore related subjects

Biotin Complement C8 Complement Membrane Attack Complex Complement System Proteins Enzyme-Linked Immunosorbent Assay Humans Journal Article Research Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

S Bhakdi, M Roth, F Hugo. 1989-07-06. Biotinylation: a simple method for labelling complement component C8 with preservation of functional activity.. https://doi.org/10.1016/0022-1759(89)90420-1

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

A nonradioactive biochemical characterization of membrane proteins using enhanced chemiluminescence.

Here we demonstrate a nonradioactive immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) technique which replaces the standard practice of isotopic protein labeling by iodination or metabolic tagging in the analysis of membrane proteins. The technique has proved extremely valuable in the biochemical analysis of small quantities of frozen, pathological tissue. Membranes were prepared from Dx3 (a human melanoma cell line), C6 (a rat glial cell line), and osteoclastoma (a human giant cell tumor of bone). The membranes were labeled with biotin and immunoprecipitated with a variety of antibodies to the vitronectin receptor (VNR). The VNR proteins were resolved by SDS-PAGE and immunoblotted onto nitrocellulose paper. The biotinylated protein was visualized using streptavidin horseradish peroxidase and enhanced chemiluminescence (ECL). Film exposures ranged from 15 min to 16 h. Good visualization of the VNR, yielding the typical heterodimeric receptor of 90 and 150 kDa, was given. Signals generated were high and background noise low with a 30-min film exposure. An overnight exposure increased the detection of weaker bands. In conclusion, biotinylation of membrane proteins proved a satisfactory label for immunoprecipitation and SDS-PAGE analysis. The ECL development stage was extremely flexible with visualization of strong and weak signals. The method has several advantages over a conventional radioactive immunoprecipitation in that it is relatively inexpensive, simple, quick and nonhazardous.

Biotin↗

PubMed1992

Characterization of biotinylated repair regions in reversibly permeabilized human fibroblasts.

We have examined the incorporation of biotinyl-11-deoxyuridine triphosphate (BiodUTP) into excision repair patches of UV-irradiated confluent human fibroblasts. Cells were reversibly permeabilized to BiodUTP with lysolecithin, and biotin was detected in DNA on nylon filters using a streptavidin/alkaline phosphatase colorimetric assay. Following a UV dose of 12 J/m2, maximum incorporation of BioUTP occurred at a lysolecithin concentration (80-100 micrograms/mL) similar to that for incorporation of dTTP. Incorporation of BiodUTP into repair patches increased with UV dose up to 4 and 8 J/m2 in two normal human fibroblast strains, while no incorporation of BiodUTP was observed in xeroderma pigmentosum (group A) human fibroblasts. The repair-incorporated biotin was not removed from the DNA over a 48-h period, and only slowly disappeared after longer times (approximately 30% in 72 h), while little of the biotin remained in cells induced to divide. Furthermore, the stability of the biotin in repaired DNA was unaffected by a second dose of UV radiation several hours after the biotin-labeling period to induce a "second round" of excision repair. Exonuclease III digestion and gap-filling with DNA polymerase I indicate that the majority of biotin-labeled repair patches (approximately 80%) are rapidly ligated in confluent human cells. However, the remaining patches were not ligated after a 24-h chase period, in contrast to dTTP-labeled repair patches. The BiodUMP repair label in both chromatin and DNA is preferentially digested by staphylococcal nuclease, preventing the use of this enzyme for nucleosome mapping in these regions.(ABSTRACT TRUNCATED AT 250 WORDS)

Biotin↗

PubMed1992

Identification of a novel low-affinity receptor for human interleukin-7.

Human recombinant interleukin-7 (IL-7) was labeled with biotin and used to examine IL-7 receptor (IL-7R) expression and regulation on human primary hematopoietic cells, the monocytoid line THP1, and a range of B- and pre-B-celi lines by flow cytometry. A strong intensity of staining was observed using relatively high (greater than 1 x 10(-7) mol/L) concentrations of biotinylated IL-7 on the majority of cell types examined. This reactivity, which could be effectively competed with excess unlabeled IL-7, did not correlate with either mRNA levels for the cloned receptor or with estimates of IL-7R expression determined by [125I]IL-7 binding. Staining of cells with a titration of biotinylated IL-7 showed, at concentrations greater than 1 x 10(-7) mol/L binding with a Ka in the range of 1 x 10(6) mol/L-1, to 1 x 10(7) mol/L-1, an affinity 100 to 1,000 times lower than that reported for the cloned IL-7 receptor. Further data suggesting the existence of a distinct low- affinity IL-7R were provided by two antibodies specific for the cloned IL-7R. Staining with these monoclonal antibodies (MoAbs) correlated with both IL-7R mRNA levels and receptor expression determined by [125I]IL-7 binding, but was not compatible with the distribution of reactivity seen with biotinylated IL-7. Using tritiated biotin to label IL-7, it was estimated that the total number of IL-7 binding sites on the cell lines examined ranged from 1 x 10(4) to at least 5 x 10(5)/cell. Cross-linking studies showed that [125I]IL-7 associated with two major proteins of approximately 62 Kd and 70 Kd on the surface of RPMI 1788 and THP1 cells, in contrast to the 75- to 80 Kd molecule characteristic of the previously cloned receptor, expressed on the surface of Daudi cells. Proliferation of THP1 cells, expressing only the low-affinity form of IL-7R and lacking detectable IL-7R mRNA, could be inhibited by the addition of IL-7 in a concentration-dependent fashion, indicating that, at least on this cell line, binding of IL-7 with a Ka of 1 x 10(6) mol/L-1 to 1 x 10(7) mol/L-1 can transduce a biological signal. Taken together, the data contained in this report demonstrate the existence of a low-affinity IL-7R, expressed in high numbers on hematopoietic cells of different lineages, which is the product of a gene distinct from that encoding the cloned IL-7R.

Biotin↗